Activating SRC mutation in a subset of advanced human colon cancers
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The discovery of Rous sarcoma virus (RSV) led to the identification of cellular Src (c-Src), a non-receptor tyrosine kinase, which has since been implicated in the development of numerous human cancers. c-Src has been found to be highly activated in colon cancers, particularly in those metastatic to the liver. Studies of the mechanism of c-Src regulation have suggested that c-Src kinase activity is downregulated by phosphorylation of a critical carboxy-terminal tyrosine (Tyr 530 in human c-Src, equivalent to Tyr 527 in chicken Src) and have implied the existence of activating mutations in this C-terminal regulatory region. We report here the identification of a truncating mutation in SRC at codon 531 in 12% of cases of advanced human colon cancer tested and demonstrate that the mutation is activating, transforming, tumorigenic and promotes metastasis. These results provide, for the first time, genetic evidence that activating SRC mutations may have a role in the malignant progression of human colon cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. M., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,498
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,418
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
STEHELIN, D., VARMUS, H. E., BISHOP, J. M., & VOGT, P. K. (1976) · Nature · doi:10.1038/260170a0 · Cited by 1,321 · cited 1×
“We targeted this region for mutational screening because it is known to contain the principal regulatory phosphotyrosine (Tyr 530; Ref”
BackgroundIdentification of a transformation-specific antigen induced by an avian sarcoma virus
BRUGGE, J. S., & ERIKSON, R. L. (1977) · Nature · doi:10.1038/269346a0 · Cited by 888
Kmiecik, T. E., & Shalloway, D. (1987) · Cell · doi:10.1016/0092-8674(87)90756-2 · Cited by 623
Tyr 527 Is Phosphorylated in pp60 c- src : Implications for Regulation
Cooper, J. A., Gould, K. L., Cartwright, C. A., & Hunter, T. (1986) · Science · doi:10.1126/science.2420005 · Cited by 540 · cited 1×
“We targeted this region for mutational screening because it is known to contain the principal regulatory phosphotyrosine (Tyr 530; Ref”
BackgroundThe when and how of Src regulation
Cooper, J. A., & Howell, B. (1993) · Cell · doi:10.1016/0092-8674(93)90634-3 · Cited by 533
Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src
Piwnica-Worms, H., Saunders, K. B., Roberts, T. M., Smith, A. E., & Cheng, S. H. (1987) · Cell · doi:10.1016/0092-8674(87)90757-4 · Cited by 520
Cell Transformation by the Viral src Oncogene
Jove, R., & Hanafusa, H. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.000335 · Cited by 401
Self-citationIncrease in activity and level of pp60c-src in progressive stages of human colorectal cancer.
Talamonti, M. S., Roh, M. S., Curley, S. A., & Gallick, G. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116200 · Cited by 399
Cited by
Items 301–400 of 507
Tsang, J. L. Y., Jia, S. H., Parodo, J. C., Plant, P. J., Lodyga, M., Charbonney, E., Szászi, K., Kapùs, A., & Marshall, J. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153946 · Cited by 22
Clinical significance of Src expression and activity in human neoplasia.
Chatzizacharias, N. A., Kouraklis, G. P., Giaginis, C., & Theocharis, S. E. (2012) · PubMed · doi:10.14670/hh-27.677 · Cited by 26
“Finally, point mutations that truncate the protein at a point proximal to the carboxyterminal regulatory part have been shown to lead to activation in colon and endometrial carcinomas (Yamaguchi and Hendrickson, 1996; Irby et al., 1999; Sugimura et al., 2000).”
BackgroundInfluentialGenomic Approaches for Reconstructing Gene Networks
Lee, N. H. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.3.245 · Cited by 21
The C Terminus of c-Src Inhibits Breast Tumor Cell Growth by a Kinase-independent Mechanism
Ishizawar, R. C., Tice, D. A., Karaoli, T., & Parsons, S. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312368200 · Cited by 25
Fu, S., Huang, Y.-J., Liang, F.-P., Huang, Y., Chuang, C.-F., Wang, S., & Yao, J.-W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.045 · Cited by 21
Ono, M., Takeshima, M., Nishi, A., Higuchi, T., & Nakano, S. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1797835 · Cited by 22
“Mutation in the regulatory domain of csrc has been reported as a mechanism of Src activation (11) and Src kinase has been demonstrated to be activated in human cancer including breast (12,13), colon (14,15), bladder (16), and pancreas cancers (17).”
BackgroundSRC inhibition represents a potential therapeutic strategy in liposarcoma
Sievers, E., Trautmann, M., Kindler, D., Huss, S., Gruenewald, I., Dirksen, U., Renner, M., Mechtersheimer, G., Pédeutour, F., Åman, P., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29645 · Cited by 21
“, in a subset of advanced colon cancers.(17) Representing a more common way of SRC induction, activation of receptor tyrosine kinases such as EGFR, PDGFR, IGF-IR, FGFR and MET lead to their association with the SRC SH2 domain resulting in augmented and synergistic SRC activation.”
BackgroundAlt‐Holland, A., Sowalsky, A. G., Szwec-Levin, Y., Shamis, Y., Hatch, H., Feig, L. A., & Garlick, J. A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.188 · Cited by 20
“In colon cancer, increased Src expression has been found in preneoplastic lesions and activating mutations are seen in metastatic foci (Irby et al., 1999).”
BackgroundActivation of the Serine/Threonine Protein Kinase AKT During the Progression of Colorectal Neoplasia
Saglam, O., Garrett, C. R., Boulware, D. C., Sayegh, Z., Shibata, D., Malafa, M. P., Yeatman, T. J., Cheng, J. Q., Sebti, S. M., & Coppola, D. (2007) · Clinical Colorectal Cancer · doi:10.3816/ccc.2007.n.034 · Cited by 20
Self-citationGueto, C., Ruiz, J. L. F., Torres, J. E., Méndez‐Hurtado, J., & Vivas‐Reyes, R. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.053 · Cited by 20
Bistable switching and excitable behaviour in the activation of Src at mitosis
Fuß, H., Dubitzky, W., Downes, S., & Kurth, M. J. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl201 · Cited by 20
“The switch is operated by the tyrosine kinase CSK, which itself is involved in a negative feedback loop with Src. Negative feedback generates an excitable system, which produces transient activation of Src.”
BackgroundAlaoui‐Jamali, M. A., & Qiang, H. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00024-4 · Cited by 21
“, 1993) and increased metastatic potential (Irby et al., 1999), and cooperation between Src and ErbB in tumorigenesis and invasion has been reported (Dankort and Muller, 2000; Maa et al.”
BackgroundShimada, Y., Muneoka, Y., Nagahashi, M., Ichikawa, H., Tajima, Y., Hirose, Y., Ando, T., Nakano, M., Sakata, J., Kameyama, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39328-6 · Cited by 19
Teli, G., Pal, R., Maji, L., Matada, G. S. P., & Sengupta, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2205943 · Cited by 19
“It has been suggested that Src contributes to the development of human colon cancers (Guarino, 2010; Irby et al., 1999).”
BackgroundHernández, H. N. C., Contreras, J., Soriano‐Maldonado, P., Sánchez, J., Yeung, W., Martín-Hurtado, A., Muñoz, I. G., Kannan, N., Llimargas, M., Muñoz, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41890-7 · Cited by 19
“However, c-Src activating mutations or ampli fi cations are rare in human cancers 31,32 , with the exception of colorectal cancer 33 .”
Bénistant, C., Chapuis, H., Mottet, N., Noletti, J., Crapez, E., Balì, J.-P., & Roche, S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2948 · Cited by 19
Activation of signal pathways and the resistance to anti‐EGFR treatment in colorectal cancer
Chen, J., Huang, X., & Katsifis, A. G. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22905 · Cited by 20
“Src/PI3K/Akt PATHWAY MUTATION With approximately 12% of CRC patients identified to have Src activating mutation [Irby et al., 1999; Chen, 2008] and about 80% have over-expression of Src, this pathway has been demonstrated to play an important role in colorectal cancer [Chen, 2008].”
BackgroundPoon, C. L. C., Brumby, A. M., & Richardson, H. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061585 · Cited by 20
“Aberrant Src activation correlates with advanced cancer development and is associated with tumour characteristics, such as increased invasiveness and metastasis [6,7,15,17].”
BackgroundThe role of death-associated protein kinase (DAPK) in endothelial apoptosis under fluid shear stress
Rennier, K. R., & Ji, J. Y. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.06.011 · Cited by 21
Huveneers, S., & Danen, E. H. J. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.114 · Cited by 19
“To address this, we investigated the oncogenic properties of a primed mutant of c-Src (SrcY530F), which mimics the primed state induced by overexpression of RTKs, and corresponds to Cterminal mutants of c-Src found in subsets of patients with colon and endometrial cancer[15,16].”
BackgroundYang, M.-Z., Zhang, B., Huang, J., Bai, X.-Y., Liang, Z., Xiang, Y., Xu, N., Huang, Y.-J., & Jiao, A.-J. (2021) · Bioinorganic Chemistry and Applications · doi:10.1155/2021/9959634 · Cited by 18
“It is worth mentioning that SRC mutations rarely occur in human tumors [34].”
BackgroundRetractedBcr interferes with β‐catenin–Tcf1 interaction
Reß, A., & Moelling, K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.034 · Cited by 18
“cancers [30] suggests that Src(Y527F) may contribute to cancer.”
BackgroundKinetics of v-src-induced epithelial–mesenchymal transition in developing glandular stomach
Shimizu, Y., Yamamichi, N., Saitoh, K., Watanabe, A., Ito, T. K., Yamamichi-Nishina, M., Mizutani, M., Yahagi, N., Suzuki, T., Sasakawa, C., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206174 · Cited by 18
“In human carcinomas, a mutant of c-Src truncated at codon 531 that has activating potential was isolated in a subset of advanced human colon cancers (Irby et al., 1999), although the frequency of this mutant may be very low (Daigo et al., 1999).”
BackgroundFunctional analysis of GNG2 in human malignant melanoma cells
Yajima, I., Kumasaka, M. Y., Tamura, H., Ohgami, N., & Kato, M. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.09.009 · Cited by 19
“The c-SRC and PI3K/ATK pathways are associated with Gprotein-related cell proliferation and survival in various kinds of human cancers including malignant melanoma [7,20–23].”
BackgroundKline, C. L. B., & Irby, R. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0648-3 · Cited by 17
Self-citationLee, S., Kim, J., Lee, J., Lee, J., Park, J., Han, T.-S., Cho, Y., Cho, Y., Bae, K., Park, Y.-J., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00628-4 · Cited by 17
Src Kinase and Pancreatic Cancer
Hilbig, A. (2007) · Springer eBooks · doi:10.1007/978-3-540-71279-4_19 · Cited by 18
Maślikowski, B. M., Néel, B., Wu, Y., Wang, L., Rodrigues, N., Gillet, G., & Bédard, P. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-41 · Cited by 18
Connections count in cell migration
Vuori, K., & Ruoslahti, E. I. (1999) · Nature Cell Biology · doi:10.1038/12081 · Cited by 17
Insig2 is associated with colon tumorigenesis and inhibits Bax‐mediated apoptosis
Li, C. G., Gruidl, M., Eschrich, S. A., McCarthy, S. M., Wang, H., Alexandrow, M. G., & Yeatman, T. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23510 · Cited by 17
“A cell anchorage independent growth assay was done according to a previously published protocol.(11) Three stable HCT116Insig2-Myc clones (clones 1–3) and control cells (pcDNA3.”
MethodSelf-citationSrc kinase induces tumor formation in the c‐SRC C57BL/6 mouse
Kline, C. L. B., Jackson, R. J., Engelman, R. W., Pledger, W. J., Yeatman, T. J., & Irby, R. (2008) · International Journal of Cancer · doi:10.1002/ijc.23445 · Cited by 17
“Fibroblasts transfected with activated Src show a transformed phenotype when used in soft agar assays and in nude mouse models of metastasis.(21) Src has been shown to increase migration and invasion of human colon cancer cells in vitro.”
BackgroundMethodSelf-citationAdvani, G., Lim, Y. C., Catimel, B., Lio, D. S. S., Ng, N. L. Y., Chüeh, A. C., Tran, M. X., Anasir, M. I., Verkade, H. M., Zhu, H., et al. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0186-x · Cited by 17
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma
Tsao, A. S., Lin, H. Y., Carter, B. W., Lee, J. J., Rice, D. C., Vaporcyan, A., Swisher, S. G., Mehran, R. J., Heymach, J. V., Nilsson, M. B., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.10.033 · Cited by 15
The Pathogenic Effect of Cortactin Tyrosine Phosphorylation in Cutaneous Squamous Cell Carcinoma
Zhu, L., Cho, E. S., Zhao, G., Roh, M. R., & Zheng, Z. (2019) · In Vivo · doi:10.21873/invivo.11486 · Cited by 15
Selective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src Kinase
Agius, M. P., Ko, K. S., Johnson, T. K., Kwarcinski, F. E., Phadke, S., Lachacz, E. J., & Soellner, M. B. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00306 · Cited by 15
HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
Zhu, X., Zhang, Y., Bai, Y., Gu, X., Chen, G., Sun, L., Wang, Y., Qiao, X., Ma, Q., Zhu, T., et al. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.43161 · Cited by 17
“Increased HCK expression was also found in pancreatic cancer, CRC, gastric cancer, and other solid malignancies [16-18].”
BackgroundInfluentialWang, D., Gao, J., Zhao, C., Li, S., Zhang, D., Hou, X., Zhuang, X., Liu, Q., & Luo, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.560572 · Cited by 16
“Thus, the two proteins are mutually activated (36, 37).”
BackgroundChüeh, A. C., Advani, G., Foroutan, M., Smith, J., Ng, N. L. Y., Nandurkar, H. H., Lio, D. S. S., Zhu, H., Chong, Y., Verkade, H. M., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01755-z · Cited by 16
Self-citationDe novo variant in tyrosine kinase SRC causes thrombocytopenia: case report of a second family
Kock, L. D., Thys, C., Downes, K., Duarte, D., Mégy, K., Geet, C. V., & Freson, K. (2019) · Platelets · doi:10.1080/09537104.2019.1628197 · Cited by 15
“In advanced human colon cancer, a truncating somatic variant in SRC at codon 531 was reported in 12% of cases to cause activation of SRC and promote metastasis [2].”
BackgroundWu, S. S., Yamauchi, K., & Rozengurt, E. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.06.001 · Cited by 15
Ali, N., Yoshizumi, M., Yano, S., Sone, S., Ohnishi, H., Ishizawa, K., Kanematsu, Y., Tsuchiya, K., & Tamaki, T. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0060357 · Cited by 15
CSK-mediated signalling by integrins in cancer
Maldonado, H., & Leyton, L. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1214787 · Cited by 14
“Although SFKmutations that can increase the catalytic activity of these kinases (Irby et al., 1999; Turro et al., 2016), they are rare in patients, and most of the reported evidence suggests that increased activation of SFKs is primarily caused by dysregulation of upstream signalling pathways, such as CSK-dependent in…”
BackgroundEpidermal hyperplasia and papillomatosis in mice with a keratinocyte-restricted deletion of csk
Honda, K., Sakaguchi, T., Sakai, K., Schmedt, C., Ramı́rez, Á., Jorcano, J. L., Tarakhovsky, A., Kamisoyama, H., & Sakai, T. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm112 · Cited by 14
Kollmorgen, G., Bossenmaier, B., Niederfellner, G. J., Häring, H., & Lammers, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053050 · Cited by 13
“Carboxy-terminal truncation of Src is also found in rare cases of human tumors [6].”
BackgroundNovel Small-Molecule Inhibitors of Src Kinase for Cancer Therapy
Sawyer, T. K. (2007) · Topics in medicinal chemistry · doi:10.1007/7355_2006_010 · Cited by 14
DNA Copy Number Changes in Lung Adenocarcinoma in Younger Patients
Lindström, I., Nordling, S., Nissén, A., Tammilehto, L., Mattson, K. V., & Knuutila, S. (2002) · Modern Pathology · doi:10.1038/modpathol.3880533 · Cited by 12
“The mutation has been demonstrated to be activating, transforming, tumorigenic, and metastasis promoting (35).”
BackgroundCarbazolequinone induction of caspase-dependent cell death in Src-overexpressing cells
Aouacheria, A., Néel, B., Bouaziz, Z., Rigal, D., Walchshofer, N., Pâris, J., Fillion, H., & Gillet, G. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01385-0 · Cited by 12
Kunte, D. P., Wali, R. K., Koetsier, J. L., & Roy, H. K. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0022 · Cited by 11
“events (17) or transcriptional overexpression (18), by far the most common mechanism of Src activation is through down-regulation of its negative regulator, COOH-terminal”
BackgroundCapurso, G., Florio, A. D., Sette, C., & Fave, G. D. (2012) · Neuroendocrinology · doi:10.1159/000336093 · Cited by 12
Al-jeboori, T., Abdulamir, A. S., Hafidh, R. R., Mahdi, L. K., Abubaker, F., & Abbas, K. (2008) · American Journal of Immunology · doi:10.3844/ajisp.2008.14.22 · Cited by 11
“In this context, p21/waf1/cip1 has been shown to act as a CDK inhibitor and is located on chromosome 6 in position p21([16-20]).”
BackgroundSubunit S5a of the 26S proteasome is regulated by antiapoptotic signals
Gus, Y., Karni, R., & Levitzki, A. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05815.x · Cited by 11
Novel Targets for Anticancer Treatment Development in Colorectal Cancer
Macarulla, T. M., Ramos, F. J., Capdevila, J., Saura, C., & Tabernero, J. M. (2006) · Clinical Colorectal Cancer · doi:10.3816/ccc.2006.n.045 · Cited by 12
Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas.
Pisano, C., Ottaiano, A., Tatangelo, F., Bonito, M. D., Falanga, M., Iaffaioli, V. R., Botti, G., Pignata, S., & Acquaviva, A. M. (2005) · PubMed · Cited by 11
Alessandro, R., Flugy, A. M., Russo, D., Stassi, G., Leo, A. D., Corrado, C., Alaimo, G., & Leo, G. D. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20236 · Cited by 11
“…with respect to normal colonic epithelial cells (Talamonti et al., 1993; Summy and Gallick, 2003). c-src has been found to be highly activated in colon cancers, particularly in those metastatic to the liver, following activating mutations in its C-terminal regulatory region (Irby et al., 1999).”
Backgroundp60v-src and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells
Aouacheria, A., Ory, S., Schmitt, J.-R., Rigal, D., Jurdic, P., & Gillet, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205170 · Cited by 11
“Moreover, tumours display either high levels of c-src expression, particularly those of the colon (Cartwright et al., 1990, Muhlenbeck et al., 1998) or a mutated version of c-src, being crucial for tumour progression (Irby et al., 1999).”
BackgroundProteomics analysis of in vitro protein methylation during Src‐induced transformation
Chiou, Y., Fu, S., Lin, W., & Lin, C. (2012) · Electrophoresis · doi:10.1002/elps.201100280 · Cited by 10
Downregulation of AATK mediates microRNA-558-induced resistance of A549 cells to radiotherapy
Zhu, R.-X., Song, C., Yang, J., Yi, Q., Li, B., & Liu, S.-H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5579 · Cited by 11
“Activating mutations of Src have been reported in colon cancer; however, no activating mutations and gene amplifications have been identified in lung cancer (28,29).”
Fly Src: The Yin and Yang of tumor invasion and tumor suppression
Martin, G. S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.025 · Cited by 10
Transcriptional signature induced by a metastasis‐promoting c‐Src mutant in a human breast cell line
Broecker, F., Hardt, C., Herwig, R., Timmermann, B., Kerick, M., Wunderlich, A., Schweiger, M. R., Borsig, L., Heikenwalder, M., Lehrach, H., et al. (2016) · The FEBS Journal · doi:10.1111/febs.13694 · Cited by 9
Shen, J., Li, L., Howlett, N. G., Cohen, P. S., & Sun, G. (2020) · Cancers · doi:10.3390/cancers12051087 · Cited by 10
Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin
Indermaur, M. D., Xiong, Y., Kamath, S. G., Boren, T., Hakam, A., Wenham, R. M., Apte, S. M., & Lancaster, J. M. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.02.003 · Cited by 10
Wang, H.-C., Huo, Y., & Lee, W. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02077-3 · Cited by 9
Wang, L., Guo, B., Wang, R., Jiang, Y., Qin, S., Liang, S., Zhao, Y., Guo, W., Li, K., & Fan, X. (2011) · Clinical Science · doi:10.1042/cs20110230 · Cited by 9
Fang, F., Li, D., Li, J., Sun, J., Du, Q., Gong, H., & Zhu, H. (2013) · RSC Advances · doi:10.1039/c3ra45204b · Cited by 8
Ndegwa, N., Côté, R. G., Ovelleiro, D., D’Eustachio, P., Hermjakob, H., Vizcaíno, J. A., & Croft, D. W. (2011) · Database · doi:10.1093/database/bar047 · Cited by 8
“The human cellular SRC (c-SRC), a nonreceptor tyrosine kinase, is involved in numerous cellular processes such as cell proliferation, regulation of cell adhesion, invasion and motility, which are thought to contribute to tumor progression and metastasis, although this role is not yet fully understood (21, 22).”
BackgroundMomparler, R. L., & Bovenzi, V. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200005)183:2<145::aid-jcp1>3.0.co;2-v · Cited by 387
Mizenina, O. A., Musatkina, E., Yanushevich, Y. G., Rodina, A., Krasilnikov, M., de Gunzburg, J., Camonis, J., Tavitian, A., & Tatosyan, A. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011320200 · Cited by 8
Contact Normalization or Escape from the Matrix
Krishnan, H., & Goldberg, G. S. (2015) · Springer eBooks · doi:10.1007/978-94-017-7380-5_12 · Cited by 7
Sobani, Z. A., Sawant, A. S., Jafri, M., Correa, A. K., & Şahin, İ. H. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i5.340 · Cited by 9
JunD/AP-1 Antagonizes the Induction ofDAPK1To Promote the Survival of v-Src-Transformed Cells
Maślikowski, B. M., Wang, L., Wu, Y., Fielding, B. D., & Bédard, P. (2016) · Journal of Virology · doi:10.1128/jvi.01925-16 · Cited by 8
“In particular, high Src activity has been linked to poor prognosis and metastasis in breast and colon cancers (1, 2).”
BackgroundDoki, N., Kawashima, T., Nomura, Y., Tsuchiya, A., Oneyama, C., Akagi, T., Nojima, Y., & Kitamura, T. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01235.x · Cited by 8
Li, H., Ung, C. Y., Xiao, H., Liu, X. H., Li, B. W., Low, B. C., & Chen, Y. (2009) · Cancer · doi:10.1002/cncr.24485 · Cited by 7
“Src is an oncogenic kinase that frequently has increased expression in a wide array of cancers, including tumors of the breast, colon, pancreas, lung, ovary, and central nervous system.(96) Our pathway sensitivity analysis indicated that increased Src levels reduced the duration of ERK activation, whereas decreased Sr…”
ResultGrowth Factors and Oncogenes in Gastrointestinal Cancers
Tahara, E. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400104 · Cited by 7
PTPα-mediated Src activation by EGF in human breast cancer cells
Wang, J., Yu, L., & Zheng, X. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt005 · Cited by 6
Pathogenesis of Colorectal Cancer
de Leòn, M. P. (2002) · Springer eBooks · doi:10.1007/978-3-642-56008-8_2 · Cited by 6
Chicken Cells Oncogene Transformation, Immortalization and More
Plachý, J., & Hejnar, J. (2002) · Folia Biologica · doi:10.14712/fb2002048040126 · Cited by 7
Multiplex Analysis of Src Family Kinase Signaling by Microbead Suspension Arrays
Campbell, M., Lie, W., Zhao, J., Hayes, D., Mistry, J., Kung, H.-J., Luciw, P. A., & Khan, I. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2009.0255 · Cited by 7
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Rothschild, S. I., & Gautschi, O. P. (2012) · Clinical Investigation · doi:10.4155/cli.12.27 · Cited by 6
The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation
Tong, S., Liss, A. S., You, M. J., & Bose, H. R. (2006) · Oncogene · doi:10.1038/sj.onc.1210023 · Cited by 8
“…development of a variety of histologically distinct neoplasias, including lymphomas, myelomas, colon and breast cancers (Kato et al., 1986; Frykberg et al., 1987; Kralova et al., 1994; Iida et al., 1997; Nass and Dickson, 1997; Irby et al., 1999; Rayet and Gelinas, 1999; Hrdlicková et al., 2001).”
Backgroundc-src activating mutation analysis in Chinese patients with colorectal cancer
Tan, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i15.2351 · Cited by 6
The Cellular Microenvironment and Metastases
Rankin, E. B., Erler, J. T., & Giaccia, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00003-5 · Cited by 9
[Colorectal cancer (CCR): genetic and molecular alterations].
Juárez-Vázquez, C. I., & Reynoso, M. A. R. (2014) · PubMed · Cited by 14
Molecular Therapeutics Lessons from the Role of Src in Cellular Signalling
Tuháčková, Z. (2005) · Folia Biologica · doi:10.14712/fb2005051040114 · Cited by 6
Ahamed, M. S., Khanam, R., Islam, K. M. T., Tabassum, F., Amin, M. A., Fardous, J., Tashpie, N. H., Mohiuddin, A. K. M., & Mahmud, S. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2025.100618 · Cited by 5
“12 Similarly, in non-small cell lung cancer, SRC activation enhances angiogenesis and tumor growth, acting synergistically with the MEK and STAT3 signaling pathways.”
Repertoire of Protein Kinases Encoded in the Genome ofTakifugu rubripes
Rakshambikai, R., Yamunadevi, S., Anamika, K., Tyagi, N., & Srinivasan, N. (2012) · Comparative and Functional Genomics · doi:10.1155/2012/258284 · Cited by 5
“Abnormalities in the functioning of these kinases usually have implications in developmental disorders and malignancies [30, 31].”
BackgroundRoles of Raft-Anchored Adaptor Cbp/PAG1 in Spatial Regulation of c-Src Kinase
Saitou, T., Kajiwara, K., Oneyama, C., Suzuki, T., & Okada, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093470 · Cited by 5
“c-Src is frequently overexpressed and activated in a wide variety of human cancers [6,11,12], despite the fact that Csk is normally expressed and the c-src gene is not mutated [13,14].”
BackgroundChanging the course of oncogenesis: The development of tyrosine kinase inhibitors
Lacal, J. C. (2006) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2006.03.002 · Cited by 5
“This is thought to be mediated via enhanced levels of proteintyrosine phosphatase, which de-phosphorylate the C-terminal Tyr527, or mutations that prevent establishment of the inactive phosphorylated Tyr527 conformation.(44,50)”
BackgroundSrc is dephosphorylated at tyrosine 530 in human colon carcinomas
Zhu, S., Bjorge, J. D., & Fujita, D. J. (2011) · Chinese Journal of Cancer Research · doi:10.1007/s11670-011-0229-6 · Cited by 5
“In a small subset of advanced human colon cancer specimens, this elevation of Src activity has been linked to a Src truncating mutation[7].”
BackgroundSelf-citationTiganis, T. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3649-6_5 · Cited by 5
Taddei, I., Cirotti, C., Lamballe, F., Castellanet, O., Maina, F., Medici, V., Fierro, F., Corleone, G., Nicola, F. D., Fanciulli, M., et al. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03625-y · Cited by 5
“Notably, the SRC gene is rarely mutated or amplified in cancer and its hyperactivation is mainly due to the constitutive activation of RTKs, which occurs in a large majority of tumours [21].”
Biomarkers and Targeted Therapeutics in Colorectal Cancer
Meguerditchian, A. N., & Dunn, K. B. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.07.002 · Cited by 4
Src kinase slows collective rotation of confined epithelial cell monolayers
Pricoupenko, N., Marsigliesi, F., Marcq, P., Blanch-Mercader, C., & Bonnet, I. (2024) · Soft Matter · doi:10.1039/d4sm00827h · Cited by 5
“The combined effects of Src activation promote cell migration and may, in turn, facilitate invasion by increasing the metastatic potential of cells [30].”
BackgroundOverview of Genetic Diagnosis in Cancer
Korf, B. R., & Mikhail, F. M. (2007) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1001s55 · Cited by 4
Implications for Src Kinases in Hematopoiesis: Signal Transduction Therapeutics
Sinha, S., & Corey, S. J. (1999) · Stem Cells and Development · doi:10.1089/152581699319920 · Cited by 4
“With the exception of a truncating mutation of Src found in 12% of colorectal cancer (30), no mutations of Src kinases have been reported in human neoplasms.”
Src-Kinasen in der Tumortherapie
Dempke, W. C. M., & Zippel, R. (2010) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-010-1123-y · Cited by 5
“Auch sind Mutationen, die zu einer permanenten src-Aktivierung führen, in humanen Tumoren selten [13, 14].”
BackgroundMolecular Diagnosis of Hereditary Nonpolyposis Colorectal Cancer
O’Leary, T. J. (1999) · JAMA · doi:10.1001/jama.282.3.281 · Cited by 4
Dynamic Regulation of Adherens Junctions: Implication in Cell Differentiation and Tumor Development
Pelissier-Rota, M. A., Chartier, N. T., & Jacquier‐Sarlin, M. R. (2015) · Springer eBooks · doi:10.1007/978-94-017-7380-5_4 · Cited by 3
Protein Kinases and Protein Phosphatases in Signal Transduction Pathways
Sawyer, T. K. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00070-5 · Cited by 5
Reovirus as a Potential Anticancer Therapeutic
Norman, K. L., & Lee, P. W. K. (2001) · KARGER eBooks · doi:10.1159/000061722 · Cited by 3
v-Src Transformation Is Mediated through Farnesylated Proteins
Teng, S., Sun, J., Irby, R., Hamilton, A. D., Sebti, S., & Yeatman, T. J. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6184 · Cited by 3
“In addition, a truncating mutation in Src at codon 531 has recently been identified in some advanced human colon cancers [4].”
BackgroundSelf-citation
Metadata
- Authors
- Irby, R. B., Mao, W., Coppola, D., Kang, J., Loubeau, J. M., Trudeau, W., Karl, R., Fujita, D. J., Jove, R., & Yeatman, T. J.
- Affiliations
- University of South Florida (US)
- University of Calgary (CA)
- Corresponding author
- Yeatman, Timothy J.
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 187-190
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/5971
- OpenAlex
- W1594706458
- Cited by
- 489
- References
- 28
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 2 · 2023: 11 · 2022: 1 · 2021: 5 · 2020: 9 · 2019: 13 · 2018: 9 · 2017: 9 · 2016: 12 · 2015: 15 · 2014: 19 · 2013: 12 · 2012: 21
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Funders
- National Institutes of Health (5k11ca065512-03)
- National Cancer Institute (R01CA055652, CA-55652, CA65512)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- Src kinase, colon cancer, truncating mutations, non-receptor tyrosine kinase, oncogenic transformation, carcinogenesis, liver metastasis, malignant progression, Rous sarcoma virus
- MeSH terms
- Animals, Cell Line, Colonic Neoplasms, Humans, Liver Neoplasms, Lung Neoplasms, Mice, Inbred BALB C, Mice, Nude, Mutation, Neoplasm Transplantation, Transfection, Gene Expression Regulation, Neoplastic, Polymerase Chain Reaction, Genes, src, Proto-Oncogene Proteins pp60(c-src), 3T3 Cells, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.